Analysis: Kevin Warsh moves one step closer to assuming the role of Federal Reserve Chair, potentially receiving full Senate confirmation before Chairman Powell’s term ends
Svmuu reported that Kevin Warsh, nominated by U.S. President Donald Trump as the next Federal Reserve Chair candidate, received support from the Senate Banking Committee in a 13-11 vote. This paves the way for him to obtain full Senate confirmation before Powell's term ends on May 15. The nomination will subsequently proceed to a full Senate vote. Warsh’s nomination had previously been blocked by Republican Senator Tom Tillis until the Department of Justice agreed last week to temporarily suspend its criminal investigation into cost overruns related to the renovation of the Federal Reserve’s Washington headquarters. This vote makes it increasingly likely that a Fed under Warsh’s leadership will see the biggest shake-up at the U.S. central bank in years. While campaigning for Trump’s nomination, Warsh raised the prospect of a “regime change,” promising to shrink the Fed’s $6.7 trillion balance sheet, establish a new inflation management framework, and change the way the central bank communicates with the public. However, he has provided few specifics on how he intends to achieve these goals. (Jin Shi)
Source:Odaily · Source Link
Disclaimer: This content reflects only the author’s personal views and does not constitute any investment or financial advice. If you discover any content that violates regulations,Click to Report
24H Trending
-
1
Billionaire investor Chase Coleman’s Tiger Global fund disclosed in its latest 13F filing that its top five growth stocks are all focused on AI infrastructure, including TSMC, NVIDIA, Amazon, Meta, and Google.
-
2
Will the BEAM token go to zero? Could it rise to $1,000? An in-depth analysis of the Beam network and its market prospects
-
3
What Is CVP? An In-Depth Analysis of the PowerPool Ecosystem and the Investment Value of Its Token, CVP
-
4
Analysis of CRYSTAL’s Value and Investment Potential: An Examination of Multiple Projects and Risk Assessment
-
5
Analysis: The State Street Healthcare ETF (XLV) has an expense ratio of 0.08% and a diversified portfolio, while the Invesco Biotechnology ETF (PBE) has an expense ratio of 0.58% and focuses on small-cap stocks; PBE is up 10.2% year-to-date, outperforming XLV.
-
6
Ethereum Recent Rebound: Price Breaks Above $1,970, but Multiple Risks Remain
-
7
QUARTZ Coin Analysis: An Overview of the Sandclock (QUARTZ) and Unique Network’s Quartz (QTZ) Projects
-
8
MARA Stock Valuation Analysis: Marathon Digital Holdings’ Transition to AI and Long-Term Investment Outlook
-
9
What Is JGN? Analysis of the JGN (Sword Saint Coin) Project’s Positioning, Features, and Value
-
10
NVIDIA and AMD: The Two Giants of AI Computing Power in 2026—An Analysis of Market Dynamics, Financial Performance, and Opportunities for Transition into Cryptocurrency Mining
Markets Today
Recommended Reading










